Pancreatin Zdorovya forte 14,000 enteric coated tablets 50 pcs

• active substance: pancreatin;
• 1 tablet contains pancreatin 384 mg with an activity of at least 10,000 amylolytic IU (Ph. Eur. U.), 14,000 lipolytic IU, 800 proteolytic IU;
• excipients: lactose, monohydrate; microcrystalline cellulose, croscarmellose sodium, crospovidone, povidone, colloidal anhydrous silicon dioxide, magnesium stearate, polyethylene glycol, azorubin (E 122); dry mixture “Acryl-eze white”, containing talc, titanium dioxide (E 171), methacrylate copolymer, sodium lauryl sulfate, sodium hydrogen carbonate, silicon dioxide.

Hypersensitivity to porcine pancreatin/other components of the drug, acute pancreatitis, exacerbation of chronic pancreatitis, intestinal obstruction.

From the side of the digestive system: very rarely – nausea, vomiting, flatulence, diarrhea, discomfort in the epigastric area, change in the nature of stools.

Hypersensitivity reactions (including rash, itching, sneezing, lacrimation, bronchospasm, urticaria, anaphylactic reactions), perianal irritation are possible.

To be taken internally during or immediately after a meal, the tablets should be swallowed whole, without chewing, with plenty of liquid (water, fruit juices). The dosage of the drug is based on the individual needs of the patient and depends on his age, the degree of indigestion and the composition of the food.

It is recommended to take 1-2 tablets (14000-28000 MO lipase) during each meal. However, it is possible that some patients may need to increase the dose by 1.5-2 times or even more to eliminate steatorrhea and maintain proper nutritional status. It is not recommended to exceed a dose of 15,000-20,000 MO of lipase/kg of body weight/day.

The duration of treatment can vary from a few days (in the case of digestive disorders due to the consumption of excessive amounts of food) to several months or even years (in the case of the need for constant replacement therapy).

With long-term use, the simultaneous appointment of iron preparations is recommended.

The drug contains lactose, therefore, if the patient has an intolerance to some sugars, a doctor should be consulted before taking this drug.

Azorubin (E 122) can cause allergic reactions.

Use during pregnancy or breastfeeding

The safety of pancreatin use during pregnancy has not been sufficiently studied.

During pregnancy or breastfeeding, the drug should be taken as prescribed by a doctor, if the expected benefit to the mother outweighs the potential risk to the fetus/child.

Children

The drug is recommended for use by children aged 4 years and older.

The ability to influence the speed of reaction when driving vehicles or other mechanisms

Does not affect.

Symptoms: hyperuricosuria, hyperuricemia; children have constipation.

Treatment: discontinuation of the drug, adequate hydration, symptomatic therapy.

When using the drug, it is possible to reduce the absorption of iron, folic acid, and reduce the hypoglycemic effect of acarbose. When used simultaneously with antacids containing calcium carbonate and/or magnesium hydroxide, with tannin, alcohol-containing agents, the effectiveness of pancreatin decreases.

Store in the original packaging at a temperature not higher than 25 C. Keep out of the reach of children.